JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$3.21B |
| 2 |
Arthur J. Gallagher & Co
AJG
|
+$2.24B |
| 3 |
Walt Disney
DIS
|
+$2.18B |
| 4 |
Walmart Inc
WMT
|
+$1.96B |
| 5 |
McDonald's
MCD
|
+$1.91B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$2.77B |
| 2 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$2.64B |
| 3 |
Vanguard Long-Term Treasury ETF
VGLT
|
+$2.5B |
| 4 |
iShares Broad USD High Yield Corporate Bond ETF
USHY
|
+$2.23B |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.06B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.61% |
| 2 | Technology | 23.17% |
| 3 | Financials | 10.12% |
| 4 | Consumer Discretionary | 9.84% |
| 5 | Healthcare | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2751
Metropolitan Bank Holding Corp
MCB
$1.11B
| $8.72M | ﹤0.01% |
149,280
+141,107
| +1,727% | +$8.47M |
2017 Q4
28 quarters
|
|
2752
Wave Life Sciences
WVE
$745M
| $8.71M | ﹤0.01% |
704,337
+328,670
| +87% | +$4.39M |
2017 Q3
29 quarters
|
|
|
BLLD
2753
DELISTED
JPMorgan Sustainable Infrastructure ETF
BLLD
| $8.71M | ﹤0.01% |
187,400
| – | – |
2022 Q3
9 quarters
|
|
2754
Fulgent Genetics
FLGT
$591M
| $8.7M | ﹤0.01% |
471,259
+133,215
| +39% | +$2.6M |
2020 Q2
18 quarters
|
|
|
IBDQ
2755
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $8.69M | ﹤0.01% |
347,050
+23,104
| +7% | +$579K |
2019 Q4
20 quarters
|
|
|
UMH
2756
UMH Properties
UMH
$1.32B
| $8.69M | ﹤0.01% |
460,406
+49,550
| +12% | +$945K |
2014 Q4
40 quarters
|
|
|
CLDT
2757
Chatham Lodging
CLDT
$637M
| $8.69M | ﹤0.01% |
970,392
+337,842
| +53% | +$2.99M |
2013 Q2
46 quarters
|
|
2758
LegalZoom.com
LZ
$959M
| $8.66M | ﹤0.01% |
1,153,409
+585,734
| +103% | +$4.41M |
2021 Q2
14 quarters
|
|
|
DEA
2759
Easterly Government Properties
DEA
$1.11B
| $8.66M | ﹤0.01% |
304,873
+122,947
| +68% | +$3.9M |
2015 Q4
36 quarters
|
|
2760
Ultragenyx Pharmaceutical
RARE
$1.5B
| $8.66M | ﹤0.01% |
205,787
-7,423
| -3% | -$368K |
2014 Q1
43 quarters
|
|
2761
GDS Holdings
GDS
$5.52B
| $8.66M | ﹤0.01% |
364,332
-246,489
| -40% | -$5.2M |
2017 Q1
31 quarters
|
|
2762
Photronics
PLAB
$1.86B
| $8.65M | ﹤0.01% |
367,346
+199,490
| +119% | +$4.88M |
2016 Q4
32 quarters
|
|
2763
CALL
MongoDB
MDB
$28.8B
| $8.64M | ﹤0.01% |
37,100
+25,700
| +225% | +$7.26M |
2023 Q3
5 quarters
|
|
2764
PUT
Halliburton
HAL
$26.5B
| $8.62M | ﹤0.01% |
317,000
-50,900
| -14% | -$1.49M |
2023 Q2
6 quarters
|
|
|
MFA
2765
MFA Financial
MFA
$773M
| $8.6M | ﹤0.01% |
844,103
-237,122
| -22% | -$2.72M |
2013 Q2
46 quarters
|
|
2766
South Plains Financial
SPFI
$810M
| $8.6M | ﹤0.01% |
247,430
+71,656
| +41% | +$2.6M |
2019 Q2
22 quarters
|
|
|
SHYM
2767
iShares Short Duration High Yield Muni Active ETF
SHYM
$811M
| $8.59M | ﹤0.01% |
379,118
+50,543
| +15% | +$1.16M |
2024 Q2
2 quarters
|
|
2768
Calix
CALX
$2.19B
| $8.58M | ﹤0.01% |
246,199
+118,629
| +93% | +$4.18M |
2017 Q4
28 quarters
|
|
2769
Sweetgreen
SG
$1.08B
| $8.58M | ﹤0.01% |
267,670
-403,375
| -60% | -$15M |
2021 Q4
12 quarters
|
|
2770
PUT
Rockwell Automation
ROK
$50.5B
| $8.57M | ﹤0.01% |
+30,000
| New | +$8.44M |
2024 Q4
0 quarters
|
|
2771
PUT
Warrior Met Coal
HCC
$4.72B
| $8.57M | ﹤0.01% |
+158,000
| New | +$10.1M |
2024 Q4
0 quarters
|
|
2772
Genesco
GCO
$377M
| $8.55M | ﹤0.01% |
200,003
-51,139
| -20% | -$1.68M |
2013 Q2
46 quarters
|
|
2773
Turning Point Brands
TPB
$1.12B
| $8.55M | ﹤0.01% |
142,251
+19,172
| +16% | +$1.02M |
2017 Q4
28 quarters
|
|
2774
Nuveen Core Plus Bond ETF
NCPB
$53.4M
| $8.52M | ﹤0.01% |
344,893
+40,401
| +13% | +$1.02M |
2024 Q2
2 quarters
|
|
2775
PUT
Sarepta Therapeutics
SRPT
$1.85B
| $8.51M | ﹤0.01% |
70,000
-80,000
| -53% | -$9.8M |
2024 Q3
1 quarter
|
|
Similar funds
JP Morgan Chase's Q4 2024 Portfolio in Review
As of Q4 2024, JP Morgan Chase held 7,917 positions worth $1.34T, up 2.1% from $1.32T the previous quarter. Its ten largest holdings account for 24% of the portfolio.
JP Morgan Chase's Q4 2024 filing shows 509 new, 3,351 increased, 2,465 reduced and 522 closed positions. Its largest new stake was Primo Brands: 3,989,501 shares worth $123M. The largest sale was Eli Lilly, an estimated $2.77B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.
- JP Morgan Chase's largest Q4 2024 buy was Primo Brands: 3,989,501 shares worth $123M.
- JP Morgan Chase added most to Broadcom in Q4 2024, an estimated $3.21B increase.
- JP Morgan Chase's biggest Q4 2024 reduction was Eli Lilly, cutting an estimated $2.77B.
- JP Morgan Chase fully exited Stericycle Inc in Q4 2024, selling an estimated $183M.
- JP Morgan Chase's ten largest holdings make up 24% of its $1.34T portfolio in Q4 2024.
- JP Morgan Chase opened 509 new positions and closed 522 in Q4 2024.
- JP Morgan Chase's portfolio value rose 2.1% quarter-over-quarter to $1.34T.
Based on JP Morgan Chase's 13F filing for Q4 2024, filed 12 Feb 2025.